book a demo

-6th June 2011

Mirada Announces Release of XD3.4 at the SNM Annual Meeting, San Antonio, Texas

Mirada Medical, a leading provider of oncology imaging software for multidisciplinary cancer teams, announced today the release of XD3.4, the latest version of the company’s advanced diagnostics software. Mirada is currently showcasing its oncology portfolio at the Society of Nuclear Medicine (SNM) Annual Meeting in San Antonio, Texas. With this latest release, users will be able to display, quantify and track lesions on gated data, multiphase CT and multi-sequence MR. All of the clinical tools available for PET, CT, MRI, SPECT are now also available for these advanced studies including powerful fusion, and propagation of measurements and findings across gates, sequences, and unlimited timepoints. The addition of elegant workflows for these complex studies makes XD3.4 the most comprehensive diagnostic oncology imaging software on the market. “Scanners today can produce sophisticated data showing motion of organs and lesions, but often there is no software provided which can really leverage the diagnostic power of the images produced.” says Dr. Timor Kadir, Chief Scientist at Mirada. “We have built the tools and technology for clinical experts to properly load, display and work with large volumes of gated, multi-phase and multi-sequence data without having to compromise on speed or quality. No other diagnostic software available today can provide this level of support for clinical decision-making in oncology imaging.” Focusing on clinical questions as the foundation for development, Mirada built innovative 4D multimodality data workflows unique to XD3.4 to support disease-specific diagnosis, staging, therapy planning and treatment response evaluation. Simultaneous and customizable display of a PET alongside a multiphase CT scan allows a comprehensive overview of both biological tumor activity and different phases of contrast enhancement patterns. This enables, for example, better combined assessment of the vascularization and metabolism of a suspicious liver or pancreatic lesion. Multiple timepoint display of gated PET, PET/CT, CT, Planar NM and SPECT data enables superior qualitative and quantitative assessment of tracer accumulation as well as tracking the extent and effects of intrinsic motion on a suspicious lesion, for example, in the thorax. The XD3.4 release also comprises a number of significant performance features; additional user preference settings, smart VOI editing tools and fast data swapping within workflows are all targeted at increasing efficiency in those tasks which are most time consuming and repetitive. Together with optimized workflows for PET/CT reading, triple modality fusion and software fusion based MR-PET, the new XD3.4 release from Mirada is the essence of the company’s innovative approach to diagnostic imaging in oncology. Mirada’s full portfolio of software including XD3.4 is on show at SNM, booth 4027, until June 7th.